About Dapa-Met XR Tablet 5mg / 1000mg
Extended release tablet combining Dapagliflozin and Metformin for type 2 diabetes control.
Uses
- Improving blood glucose control in adults with type 2 diabetes
- Used alongside diet and exercise when metformin alone does not control blood sugar
- Reducing the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular risk factors
Benefits
- Combines two glucose lowering mechanisms in a single tablet, which improves adherence
- Extended release formulation allows once daily dosing with fewer stomach related side effects
- Linked to modest weight loss and lower blood pressure compared to metformin alone
- May lower the risk of kidney function decline in people with type 2 diabetes
What Experts Say
Dapagliflozin inhibits the SGLT2 transporter in the renal proximal tubule, which reduces glucose reabsorption and increases urinary glucose excretion. This action lowers plasma glucose independent of insulin secretion or insulin sensitivity, which makes it useful even in patients with reduced beta cell function.
Metformin hydrochloride reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity, increasing glucose uptake in skeletal muscle. The extended release formulation slows drug release over several hours, which supports steady plasma levels and once daily dosing while lowering the frequency of gastrointestinal side effects seen with immediate release metformin.
Combining these two mechanisms addresses insulin resistance and excess glucose reabsorption at the same time, giving additive glycemic control beyond what either agent achieves alone. Clinical data also links dapagliflozin to modest reductions in body weight and blood pressure, which adds cardiometabolic benefit for many patients with type 2 diabetes.
Drug Class
- SGLT2 inhibitor combined with a biguanide, extended release
Dapa-Met XR Tablet 5mg / 1000mg Uses in Urdu
- ٹائپ 2 ذیابیطس کے مریضوں میں خون میں شوگر کی سطح کو کنٹرول کرنے کے لیے استعمال ہوتی ہے
- جب اکیلا میٹفارمن شوگر کو قابو نہ رکھ سکے تو اسے خوراک اور ورزش کے ساتھ دیا جاتا ہے
- دل کی ناکامی کی وجہ سے ہسپتال داخلے کا خطرہ کم کرنے میں مدد دیتی ہے
- وزن اور بلڈ پریشر میں معمولی کمی لانے میں معاون ہے
- گردوں کی حفاظت میں بھی کچھ حد تک مددگار ثابت ہوئی ہے
Dapa-Met XR Tablet 5mg / 1000mg formula
- Dapagliflozin + Metformin Hydrochloride
How to use Dapa-Met XR Tablet 5mg / 1000mg?
- Take this tablet once daily with the evening meal unless the doctor advises otherwise
- Swallow the tablet whole, never crush, split, or chew it because this breaks the extended release coating
- Follow the prescribed dose exactly, since the strength depends on prior metformin and dapagliflozin use
- Keep taking the recommended diet and exercise plan alongside this medicine
- Do not skip doses, since inconsistent use lowers blood glucose control
Drug Interactions
- Insulin or sulfonylureas: Combined use raises the risk of low blood sugar, so dose adjustment is often needed.
- Diuretics: Water pills increase the risk of dehydration and low blood pressure when taken with dapagliflozin.
- Iodinated contrast dye: Contrast agents used in imaging raise the risk of kidney injury and lactic acidosis when combined with metformin.
- Alcohol: Heavy alcohol intake increases the risk of lactic acidosis and low blood sugar.
- Corticosteroids: Steroid medicines can raise blood glucose and reduce how well this combination controls sugar levels.
- ACE inhibitors or ARBs: These blood pressure medicines can add to the blood pressure lowering effect of dapagliflozin.
- Cimetidine: This medicine can raise metformin levels in the blood by reducing its clearance.
Risks and warnings
- Kidney function: This combination is not recommended in patients with significant kidney impairment, since both ingredients depend on renal clearance and dapagliflozin loses effectiveness as kidney function drops.
- Ketoacidosis risk: SGLT2 inhibitors carry a rare risk of diabetic ketoacidosis, which can occur even with near normal blood glucose, so unusual nausea, vomiting, or abdominal pain need urgent medical review.
- Lactic acidosis: Metformin carries a rare but serious risk of lactic acidosis, particularly in patients with kidney disease, liver disease, or heavy alcohol use.
- Volume depletion: Dapagliflozin increases urine output, so patients on diuretics or older adults are more prone to dehydration and low blood pressure.
- Genital infections: SGLT2 inhibitors raise the risk of yeast and urinary tract infections due to increased glucose in the urine.
- Surgery or imaging procedures: This medicine should be stopped before scheduled surgery or contrast dye procedures, as advised by the treating doctor.
- Pregnancy and breastfeeding: This combination is not recommended during pregnancy or breastfeeding, and doctors usually switch patients to insulin during this period.
Dapa-Met XR Tablet 5mg / 1000mg Side Effects
- Nausea or upset stomach
- Diarrhea or loose stools
- Reduced appetite
- Increased urination
- Genital yeast infections
- Urinary tract infections
- Mild dizziness from fluid loss
- Metallic taste in the mouth
- Diabetic ketoacidosis, even with normal or mildly elevated blood glucose
- Signs of lactic acidosis such as severe weakness, muscle pain, and trouble breathing
- Sudden kidney function decline
- Severe allergic reaction with swelling or rash
Storage Conditions
- Store below 30 degrees Celsius in a cool, dry place
- Keep the tablets in their original blister pack until use
- Protect the medicine from direct sunlight and moisture
- Keep out of reach of children
- Discard any expired or unused tablets safely
